Mangalam and his team from Mayo Clinic — where all of the work was completed before Mangalam joined the UI in 2015 —
conducted microbiome analysis on fecal samples collected from MS patients as well as healthy control subjects.
Not exact matches
Overexpression of human amyloid - β protein precursor (AβPP) within the gut was assessed by qPCR and IHC; fecal
microbiome analysis was
conducted by 16SrRNA quantitation of selected phyla and species.
Procrustes
analyses of core and cortex samples were
conducted as a control study to assess the fecal
microbiome in the coprolites and to see any differences from obvious soil contaminants.